Zur Rose Group increases its financial targets
(WorldNews Switzerland)

Press release Zur Rose Group increases its financial targets - Successful acquisition strategy enables higher sales growth - Further efficiency increase expected after completion of expanded logistics centre in Heerlen - EBITDA margin target increased to 5 to 6 percent in 2022 - Confirmation of revenue and earnings expectations for 2018 Due to the successful acceleration of the strategy driven by the acquisitions of Eurapon, Vitalsana, apo-rot, Promofarma and medpex, the Zur Rose Group is raising its medium-term financial targets. For 2019, the Group is targeting sales of at least CHF 1.6...